RBC Capital analyst Ben Hendrix reiterated an Outperform rating and $123 price target on Addus HomeCare, saying the firm remains buyers on weakness related to the CMS notice of proposed rulemaking for Home and COmmunity-Based Services. The firm believes the initial selloff is overdone and sees a solid buying opportunity, as it expects little direct read-through of CMS’ headline number of 80% to Addus’ cost of sales.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ADUS: